Eisai

4523.TSE

29.95 USD

-1.15

-3.70%

Overview

Last close

29.95 usd

Market cap

8.44B usd

52 week high

39.48 usd

52 week low

24.09 usd

Target price

31.46 usd

Valuation

P/E

27.2478

Forward P/E

32.6797

Price/Sales

1.6617

Price/Book Value

1.5095

Enterprise Value

7.87B usd

EV/Revenue

1.5583

EV/EBITDA

11.3882

Key financials

Revenue TTM

5.08B usd

Gross Profit TTM

3.95B usd

EBITDA TTM

559.03M usd

Earnings per Share

1.1 usd

Dividend

1 usd

Total assets

9.49B usd

Net debt

-564.15M usd

About

Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals. It also offers prescription medicines. In addition, the company focuses on neurology and oncology and therapeutic areas. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.